CLINICAL CASE OF SUCCESSFUL 10-YEAR AMBRIZENTAN TREATMENT OF THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

CLINICAL CASE OF SUCCESSFUL 10-YEAR AMBRIZENTAN TREATMENT OF THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

Idiopathic pulmonary arterial hypertension (IPAH) is a rare cardiovascular disease of unknown etiology, characterized by pulmonary vascular resistance (PVR) and pulmonary artery pressure (PAP) increase due to pronounced remodeling of small pulmonary arteries and arterioles, with progressive deterior...

Full description

Saved in:
Bibliographic Details
Main Authors: T. V. Martynyuk, M. A. Saidova, N. M. Danilov, V. K. Lazutkina, I. Ye. Chazova
Format: Article
Language:Russian
Published: InterMedservice 2015-12-01
Series:Евразийский Кардиологический Журнал
Subjects:
idiopathic pulmonary hypertension
endothelin-1
endothelin receptor antagonists
ambrisentan
идиопатическая лёгочная гипертензия
эндотелин-1
антагонисты рецепторов эндотелина
амбризентан
Online Access:https://www.heartj.asia/jour/article/view/5655
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.heartj.asia/jour/article/view/5655

Similar Items